What pharmaceutical companies are in Basel?

Companies

• Hoffmann-La Roche: Basel.
• Novartis: Basel.
• Alcon: Geneva.
• Bayer: Basel (Consumer Health Division, Hemophilia & Ophthalmology Pharma Global HQ Divisions with some Oncology)
• Lonza Group: Basel.
• Abbott: Basel (Established Pharmaceuticals Division)
• Galenica: Bern.
• Actelion (Johnson & Johnson): Basel.

Is Pfizer Swiss or American?

Pfizer Inc. (/ˈfaɪzər/ FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The company was established in 1849 in New York by two German immigrants, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).

Where is Roche located in Switzerland?

Basel, Switzerland
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2019 employed about 98,000 people worldwide.

Do they speak English in Basel?

While Switzerland has four official languages, the most common language spoken in Basel is Swiss German. Many of the older Basel residents also speak English, but it is much more likely to encounter someone who only speaks Swiss-German the older they are.

Does Johnson and Johnson own Pfizer?

Johnson & Johnson has agreed to buy Pfizer, Inc.’s consumer healthcare business for $16.6 billion in cash, ending a quest to determine strategic options for the business that began in February. The deal is expected to close by the end of the year. Pfizer is the world’s largest pharmaceutical company, following Glaxo.

Where are the headquarters of the pharmaceutical industry in Switzerland?

The headquarters of Roche Diagnostics in Rotkreuz, Switzerland. The headquarters of Actelion in Allschwil. The pharmaceutical industry in Switzerland directly and indirectly employs about 135,000 people. It contributes to 5.7\% of the gross domestic product of Switzerland and contributes to 30\% of the country’s exports.

Why did Basel become the centre of the pharmaceutical industry?

From as early as 1896, the region of Basel became the centre of 19th-century pharmaceutical industries since Switzerland had no patent laws. This was in direct contrast with the surrounding European countries and led to a migration of researchers to Switzerland who wished to work without restrictions.

Why invest in Swiss pharmaceuticals?

Switzerland’s pharmaceutical industry is supported by its global reputation for high-quality production standards, for being a strategic test marketer and being able to introduce new medical products at an early stage. This recognition of quality control saves Switzerland’s pharmaceutical industry between 130-300 million Swiss francs yearly

How much does quality control save Switzerland’s pharmaceutical industry?

This recognition of quality control saves Switzerland’s pharmaceutical industry between 130-300 million Swiss francs yearly when trading with the EU, the EFTA States and Canada.